Celadon Pharmaceuticals PLC (CEL) — Cash Flow Reinvestment Rate

Latest as of June 2020: 1.27x

Celadon Pharmaceuticals PLC (CEL) has a Cash Flow Reinvestment Rate of 1.27x as of June 2020, reinvesting GBX139.75K (capex GBX139.75K ) from operating cash flow of GBX109.70K. Explore Celadon Pharmaceuticals PLC capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

1.27x

(Capex + Investments) / Operating CF

Total Reinvested

GBX139.75K

Capex + Investments

Operating Cash Flow

GBX109.70K

GBX

Capital Expenditures

GBX139.75K

GBX

Celadon Pharmaceuticals PLC Cash Flow Reinvestment Rate (2019–2019)

Historical reinvestment intensity for Celadon Pharmaceuticals PLC across 1 annual periods. Also explore Celadon Pharmaceuticals PLC asset portfolio for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Celadon Pharmaceuticals PLC (2019–2019)

Year-by-year capital reinvestment analysis for Celadon Pharmaceuticals PLC. For live market cap and broader valuation context, see Celadon Pharmaceuticals PLC market cap and net worth.

Year	Reinvestment Rate	Total Reinvested (GBX)	Operating CF	Capex	YoY Change
2019	0.00x	GBX0.00	GBX1.98K	GBX0.00	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow